# Spironolactone

NDC: 43063-974
Generic name: spironolactone
Labeler / Manufacturer: PD-Rx Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170602

FDA application: ANDA203512

## Active ingredients

- SPIRONOLACTONE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43063-974"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43063-974
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3487305c-25a6-4e82-923c-3e4dd638c988